BIOIMAGING - An Exclusive Market Insight Report from RI Technologies

RI Technologies' (www.researchimpact.com) market insight report on Bioimaging focuses on the different types and modalities of bioimaging and their application in Research and Development and Diagnostics.

Hyderabad, India (prHWY.com) November 21, 2011 - November 9, 2011 - RI Technologies' (www.researchimpact.com) market insight report on Bioimaging focuses on the different types and modalities of bioimaging and their application in Research and Development and Diagnostics. The study provides global market analysis for bioimaging by Type (Medical and Molecular) and Modalities including Ultrasound, CT, MRI, PET, SPECT and other modalities comprising X-Ray, TEM and OCT. The study includes estimations and predictions for the total global bioimaging market. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is covered in the report. A global perspective is presented along with regional analysis covering North America, Europe, Japan, Asia-Pacific, Latin America, and Rest of World with 276 exclusive graphically represented exhibits.

Bioimaging techniques are regarded as the most promising advancements in the field of present day healthcare and biomedical research. Bioimaging is being recognized as one of the most comprehensive achievements, which has eased the working conditions of the physicians. In the present medical scenario majority of the diseases are being diagnosed and attended using biomedical imaging techniques. This technique requires a good amount of development to understand the basic functions of the organs in the living system. The main aim of the concept of bioimaging is to provide an effective understanding of the numerous available imaging modalities like X-ray, Commuted Tomography, emission tomography and magnetic resonance imaging. This is done by relating the basic operating principles of these techniques with that of Imaging techniques. The intricate cellular and molecular signaling practices in the development and homeostasis could only be analyzed using complete analysis of the living organism. These requirements necessitate biomedical research and drug development to possess numerous dynamic processes in cellular physiology, development and disease conditions of living organism by employing bioimaging technologies.

Medical imaging implies development of an image of the body or part thereof that has the disease and studying this image of the anatomy vis-à-vis its function in the body. Radiology, endoscopy, thermography, microscopy, radiological sciences, and medical photography, are the normally used biomedical imaging techniques. In addition, techniques such as electroencephalography (EEG) and magnetoencephalography (MEG), which do not generate images, but generate data that could be read as maps for analyzing the abnormal variations in measurements of some process also, form part of biomedical imaging.

Molecular imaging is useful for quantitative tests, assessing how much of a drug dosage is required for achieving the target, or how much time is taken for a given reaction. Though such imaging has potential in several areas, presently it is used for understanding the molecular behavior just before the organism starts showing the symptoms of a disease. This understanding would help in early detection of diseases and infections, thereby reducing the need for drastic measures like surgery or stronger doses of drugs. Molecular bioimaging would pave the way to molecular medicines based on human genomes. It gives the visual evidence of enzyme expressions, function of reporter genes and neurotransmitters, and other processes.

More information about this report: http://researchimpact.com/Mir020.aspx

RI Technologies offers this report at 20% discount now. For customer support, you may please contact RI Technologies - Email: contactus@researchimpact.com / Phone: +91 9676994272

About RI Technologies
RI Technologies, established in 2006, is a premier source of market research on the Biotechnology & Healthcare sector with exclusive focus on product segments, global and regional market analysis, technology trends, industry outlook, competitor profiles, corporate directory and patents information. The company believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data. The dedicated team works 24/7 to deliver unique reports that are of immense value to investment banks, companies, management consultants, trade associations, corporate executives, business analysts, libraries, universities, and business schools. The company's reports provide strategic information tools to the manufacturers, retailers, distributors, and suppliers that will help them to probe into and support critical business decisions. RI Technologies believes in broadening the value of market research obtained through several dedicated streams of information. The strategic market information tables, graphically represented, will aid companies' research needs and help in forecasting, and gearing up to the future. Emphasis is on factual insights and forecasts with maximum global coverage. The company strives to provide market insight reports that empower customers with enlightening critical business information.

###

Tag Words: stem cell research

Categories: Health

Press Release Contact
RI Technologies, 2-2-1133/B/2, New Nallakunta,Hyderabad.

Link To This Press Release:

URL HTML Code